Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Crizotinib effective in patients with NSCLC harboring ROS1 gene rearrangement

Sep. 19, 2012

Merck KGaA voluntarily withdraws European application for Erbitux in NSCLC

Sep. 18, 2012

JASPAC1 01 phase III interim study results to be published

Sep. 18, 2012

Promising in vitro and in vivo results reported for novel dual c-Met/Ron inhibitor

Sep. 18, 2012

Nerviano Medical Sciences presents novel B-raf inhibitors

Sep. 18, 2012

Treanda now available in Canada

Sep. 17, 2012

Boehringer Ingelheim begins expanded access program for afatinib

Sep. 17, 2012

DMC recommends Celsion's HEAT Study continuation

Sep. 17, 2012

Georgetown University presents new AGBL2 inhibitors

Sep. 17, 2012

FDA approves production of [11C]-choline injection for PET imaging

Sep. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...